|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,510 KRW | -2.86% |
|
+3.26% | +31.35% |
| 2023 | MedPacto, Inc. announced that it has received KRW 10.85806127 billion in funding from Theragen Etex Co.,Ltd. | CI |
| 2023 | South Korean Shares Nearly Unchanged Ahead of US Inflation Data | MT |
MedPacto, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was KRW 13,971.31 million compared to KRW 4,655.06 million a year ago. Basic loss per share from continuing operations was KRW 663 compared to KRW 225 a year ago.
Basic loss per share was KRW 663 compared to KRW 225 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.35% | 232M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
MEDPACTO, INC. 
